Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States

PLoS Medicine

Volumn 12, Issue 12, 2015, Pages

  Minassian, Caroline ^a   Thomas, Sara L ^a   Smeeth, Liam ^a   Douglas, Ian ^a   Brauer, Ruth ^b   Langan, Sinéad M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; ETHNICITY; FEMALE; HEART INFARCTION; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; UNITED STATES; VACCINATION; VERY ELDERLY; COMPLICATION; INCIDENCE; MEDICARE; MYOCARDIAL INFARCTION; PHYSIOLOGY; STROKE; VARICELLA ZOSTER VIRUS; VIROLOGY;

AGED; AGED, 80 AND OVER; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; MALE; MEDICARE; MYOCARDIAL INFARCTION; STROKE; UNITED STATES;

EID: 84953775552     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001919     Document Type: Article

References (23)

1. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P, Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–2618. 15602021
2. Ridker PM, Silvertown JD, Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8 Suppl):1544–1551. doi: 10.1902/jop.2008.080249 18673009
3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220. doi: 10.1161/CIR.0b013e31823ac046 22179539
4. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS, A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341–1349. 17976353
5. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T, The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37. doi: 10.1186/1741-7015-8-37 20565946
6. Langan SM, Smeeth L, Margolis DJ, Thomas SL, Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10:e1001420. doi: 10.1371/journal.pmed.1001420 23585738
7. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA, Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8:731–740. doi: 10.1016/S1474-4422(09)70134-6 19608099
8. Langan SM, Minassian C, Smeeth L, Thomas SL, Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497–1503. doi: 10.1093/cid/ciu098 24700656
9. Breuer J, Pacou M, Gauthier A, Brown MM, Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206–212. doi: 10.1212/WNL.0000000000000038 24384645
10. Whitaker HJ, Farrington CP, Spiessens B, Musonda P, Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768–1797. 16220518
11. Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308:43–49. doi: 10.1001/jama.2012.7304 22760290
12. Lin H-C, Chien C-W, Ho J-D, Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–797. doi: 10.1212/WNL.0b013e3181d31e5c 20200348
13. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–2284. 15930418
14. Whitaker HJ, Hocine MN, Farrington CP, The methodology of self-controlled case series studies. Stat Methods Med Res. 2009;18:7–26. doi: 10.1177/0962280208092342 18562396
15. Farrington CP, Whitaker HJ, Hocine MN, Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10:3–16. doi: 10.1093/biostatistics/kxn013 18499654
16. Farrington CP, Anaya-Izquierdo K, Whitaker HJ, Hocine MN, Douglas I, Smeeth L, Self-controlled case series analysis with event-dependent observation periods. J Am Stat Assoc. 2011;106:417–426.
17. Kang J-H, Ho J-D, Chen Y-H, Lin H-C, Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443–3448. doi: 10.1161/STROKEAHA.109.562017 19815828
18. Sreenivasan N, Basit S, Wohlfahrt J, Pasternak B, Munch TN, Nielsen LP, et al. The short- and long-term risk of stroke after herpes zoster—a nationwide population-based cohort study. PLoS ONE. 2013;8:e69156. doi: 10.1371/journal.pone.0069156 23874897
19. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH, Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148:99–104. 15215798
20. Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with Medicare claims. Circ Cardiovasc Qual Outcomes. 2014;7:611–619. doi: 10.1161/CIRCOUTCOMES.113.000743 24963021
21. Mehlum M, Liestøl K, Julius S, Kjeldsen SE, Hua TA, Rothwell PM, et al. 3D.01: Visit-to-visit blood pressure variability increases risk of stroke or cardiac events in patients given valsartan or amlodipine in the VALUE Trial. J Hypertens. 2015;33(Suppl 1):e40.
22. Quantin C, Benzenine E, Velten M, Huet F, Farrington CP, Tubert-Bitter P, Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology. Am J Epidemiol. 2013;178:1731–1739. doi: 10.1093/aje/kwt207 24077093
23. Yawn BP, Wollan P, St Sauver J, Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011;174:1054–1061. doi: 10.1093/aje/kwr206 21920944